) is a potent vasoconstrictor and blood pressure modulator. Renin secretion from juxtaglomerular (JG) cells is crucial for blood pressure and electrolyte homeostasis and has been shown to be modulated by ET-1; however, the cellular and molecular mechanism of this regulation is not clear. The purpose of this study was to gain a better understanding of the cellular and molecular pathways activated by ET-1 by using a reninproducing cell line As4.1. ET-1 caused an increase in As4.1 cell intracelluar Ca 2ϩ concentration ([Ca 2ϩ ]i) mediated by the ETA receptor as its antagonist, BQ-123, abolished the response. The nitric oxide donor nitroprusside, but not 8-bromocGMP, reduced the time necessary for successive ET-1 responses. Endothelin-3 had no effect on [Ca 2ϩ ]i. ET-1 dose dependently increased total inositol phosphates with an EC 50 of 2.1 nM. ET-1 reduced renin mRNA by 68% independently of changes in message decay. With the use of a renin-luciferase reporter system in As4.1 cells, ET-1 reduced luciferase activity by 51%, suggesting that renin gene transcription is directly modified by ET-1. renin; endothelin; transcription; nitric oxide THE PHYSIOLOGICAL CONTROL of renin production and release from juxtaglomerular (JG) cells is, in part, regulated by circulating vasoactive peptides such as angiotensin II. Endothelin (ET), a potent vasoconstrictor that binds to specific membrane receptors in smooth muscle to activate phospholipase C (PLC), inositol phosphate (IP), and intracellular calcium concentration ([Ca 2ϩ ] i ), has also been implicated in the control of renin production and release.
THE PHYSIOLOGICAL CONTROL of renin production and release from juxtaglomerular (JG) cells is, in part, regulated by circulating vasoactive peptides such as angiotensin II. Endothelin (ET), a potent vasoconstrictor that binds to specific membrane receptors in smooth muscle to activate phospholipase C (PLC), inositol phosphate (IP), and intracellular calcium concentration ([Ca 2ϩ ] i ), has also been implicated in the control of renin production and release.
The effect of ET in the kidney appears to be localized to preglomerular arterioles (site of JG cells) as evidenced by its ability to cause a dose-dependent reduction in glomerular filtration (3) . There are some reports that ET can regulate [Ca 2ϩ ] i and inhibit cAMP-stimulated renin production and release (1, 19) ; however, less is known about the cellular pathways activated by ET and how they might lead to the regulation of renin at gene level. This lack of understanding has been confounded by the potential concurrent effect of the potent endothelium-derived vasodilator nitric oxide (NO), which by itself has been reported to modulate renin release (2, 12, 27) . The interactions between NO and ET pathways (9, 18) may, therefore, complicate the effect of either agent alone on renin production and secretion. In addition, it has been shown that repeated application of ET causes receptor desensitization that can be reversed by NO donors (9, 18) .
To date, the information pertaining to the cellular regulation of renin by ET has largely been obtained by using primary JG cell cultures from rats and mice. Therefore, the current study utilizes a different cellular model of renin-expressing cells, As4.1 (28) , to further our understanding of ET and how it regulates renin from the receptors, to second messengers, to renin gene regulation.
MATERIALS AND METHODS
Cell culture. As4.1 cells (ATCC No. CRL2193) are a reninexpressing clonal cell line derived from the kidney neoplasm of a transgenic mouse containing a renin promoter driven Simian virus-40 T-antigen transgene that demonstrated appropriate developmental, cell, and tissue-specific expression (28) . Cells were maintained in humidified room air containing 5% CO 2 at 37°C. As4.1 cells were cultured in DMEM supplemented with 10% fetal bovine serum. For measurement of [Ca 2ϩ ]i, As4.1 cells were cultured onto 18-mm coverslips in serum-free DMEM 24 h before the experiment. To measure total intracellular IP metabolites, As4.1 cells were cultured 48 h before the experiments onto six-well cell culture dishes in DMEM with 10% fetal bovine serum. Similarly, cells were cultured onto six-well dishes 24 h before transfection experiments, whereas renin expression was measured from As4.1 cells grown on 100-mm petri dishes.
[Ca 2ϩ ]i measurements. [Ca 2ϩ ]i in individual As4.1 cells was measured using the Ca 2ϩ -sensitive dye fura 2 as previously described (25) . As4.1 cells were washed with a Ca 2ϩ -free Ringer solution (in mM: 145 NaCl, 5 KCl, 1 MgCl2, 20 HEPES, 20 glucose, and 1 mM EGTA), followed by an incubation with 5 M fura 2-AM for 20 min, in the dark, at room temperature. After the incubation, the cells were washed with normal Ringer solution (in nM: 145 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 20 HEPES, and 20 glucose) and placed in serum-free DMEM for 1 h at room temperature and 5% CO 2. The coverslips were mounted on the stage of an inverted microscope (Diaphot-TMB, Nikon) equipped for epifluorescence using a ϫ40 oil-immersion lens. The cells were superfused with normal Ringer or 0 Ca 2ϩ Ringer, when specified, at a rate of 2-3 ml/min. The total bath volume was ϳ500 l.
Fluorescence of the fura 2-loaded cells was measured at room temperature by using a digital image analysis program Metafluor (Universal Imaging). Images were taken at excitation wavelengths of 340 and 380 nm at 3-s intervals by using a silicon-intensified target camera (Hamamatsu). The average whole cell 340/380 ratio (R) values were converted to Ca 2ϩ concentrations according to standard equations (10) (15) . Cells were incubated with myo- [2- 3 H]inositol (5 Ci/ml media) in serum-free, inositol-free DMEM 24 h before stimulation with ET. This allowed sufficient time for equilibration of the radiolabeled inositol with the membrane of the cell. To remove excess myo- [2- 3 H]inositol after the 24-h incubation, cells were washed twice with serum-and inositol-free DMEM. Cells were allowed to equilibrate in this medium for at least 1 h. Fifteen minutes before the start of an experimental protocol, medium was aspirated, followed by the addition of a Krebs solution (in mM: 118 NaCl, 4.6 KCl, 2.4 MgCl 2, 1.2 K2HPO4, 24 NaHCO3, 11 glucose, 25 HEPES, and 2.5 CaCl 2) containing 12 mM LiCl and 1 mM myoinositol. LiCl was necessary to prevent the reincorporation of IP from the cytosol to the membrane following activation of second messenger pathways.
After stimulation of the As4.1 cells with increasing doses (0.1-100 nM) of ET for 5 min each, 9% perchloric acid was added to each well to prevent the further hydrolysis of phosphotidylinositol 4,5-bisphosphate. The lysed As4.1 cell suspension was pelleted with the supernatant containing cytosolic fluid and metabolites. Pellets were saved and used in a Lowry assay to measure total protein. The supernatant was run on a Dowex column and washed with several solutions including myo-inositol (5 mM), sodium tetraborate (5 mM), and 1 M formate/0.1 M formic acid to collect the myo- [2- 3 H]-inositol from the cytosolic fraction. Myo- [2- 3 H]inositol was measured with a scintillation counter and expressed as a percentage of control IP values.
RNA isolation and Northern blot analysis. Total RNA was isolated from As4.1 cells following application of the ET-1 by using the Ultraspec RNA isolation kit (Biotecx). The method was performed according to manufacturer's instructions and utilizes the guanidium thiocyanate, acid phenol, and chloroform approach to RNA purification. Ten-microgram samples of As4.1 cell RNA were used for Northern blot analysis as previously described in our laboratory (21) . A mouse submandibular Ren 2 d cDNA was used as a probe for renin (17) , and GAPDH mRNA levels were analyzed and used as an internal control.
Renin message stability. As4.1 cell gene transcription was inhibited with actinomycin D (10 g/ml). As4.1 cells were stimulated with ET-1 (10 nM) just before the start of the experiment. At the time of 0, 6, 13, and 20 h after the addition of ET-1, total cellular RNA was harvested, and renin expression was measured by using Northern blot analysis. The same experiment was run concurrently in the absence of ET-1 to serve as a time-matched control.
DNA transfections. The luciferase derivative of a DNA construct containing the renin proximal promoter and 4,000 bp of 5Ј-flanking sequence described previously (26) was introduced to As4.1 cells via liposome-mediated transfection using Fugene 6 transfection reagent (Boehringer Mannheim). This construct contains a 5Ј-flanking sequence of the Ren-1c gene fused with the Ren-2 proximal promoter. Briefly, Fugene 6 reagent, diluted in Optimem media, was added to the DNA. This mixture was added to As4.1 cells in culture on six-well cell culture dishes 2 h before ET-1 stimulation. Six microliters of Fugene 6 was used with a total DNA amount of 3.5 g. To correct luciferase activity for variations in transfection efficiency, As4.1 cells were cotransfected with 200 ng of plasmid containing a Rous sarcoma virus (RSV) promoter driving ␤-galactosidase (RSV␤gal). As4.1 cells were transfected with a promoterless luciferase construct to determine the background luciferase activity.
Luciferase assay. Immediately after ET-1 stimulation, medium was aspirated from the six-well dishes, and cells were washed with phosphate buffer solution (in mM: 137 NaCl, 2.7 KCl, 4.3 Na 2HPO4, and 1.4 KH2PO4; pH 7.3). Luciferase activity (chemiluminescence) was measured by using the Luciferase Reporter 1000 Assay System (Promega) in accordance with manufacturer's instructions. Briefly, 1ϫ reporter lysis buffer was added to the cells to remove them from the cell culture dishes. The cells were collected in microcentrifuge tubes and subjected to a freeze-thaw cycle with dry ice and ethanol to lyse the cells completely. The lysed cells were then pelleted, and the supernatant luciferase activity was measured with a Monolight 2010 luminometer (Analytical Luminescence Laboratory). Results were expressed as percent luciferase activity of RSV luciferase-transfected cells.
␤-Galactosidase. ␤-Galactosidase activity was measured using Galacto-Light Plus Chemiluminescence Reporter Assay (Tropix) in accordance with manufacturer's instructions.
Statistical analysis. All data are presented as means Ϯ SE. Data are considered significantly different if P Ͻ 0.05, as evaluated by repeated-measures ANOVA or paired t-tests where specified. Statistical tests are noted with each figure along with the number of experiments. (Fig. 1A) . Measurements from 26 cells stimulated with ET-1 revealed a mean increase in Ca 2ϩ of 838 Ϯ 81 nM above baseline values of 69 Ϯ 3 nM (Fig. 1A, inset) . To determine whether this response is mediated via intracellular or extracellular Ca 2ϩ stores, the experiments were repeated with cells superfused in Ca 2ϩ -free containing Ringer solution (Fig. 1B) Figure 3A illustrates the occurrence of homologous desensitization of the [Ca 2ϩ ] i response to repeated application of ET-1 (10 nM, 1 min duration). The time course of spontaneous recovery from desensitization to a second (test) application of ET-1 is shown in Fig. 3B . The test responses, as compared with the first application of ET-1 (control), are shown to recover by 35 min (Fig. 3B) . However, when the control application of ET-1 is immediately followed by the superfusion of the NO donor SNP (500 M), the [Ca 2ϩ ] i response to the test application of ET-1 fully returns within 10 min (Fig. 4A) . A similar recovery from desensitization was observed with the NO donor S-nitroso-N-acetyl penicillamine (1 M) (data not shown). To investigate whether the recovery from desensitization in the presence SNP was due to a cGMP-dependent mechanism, 8-bromo-cGMP (1 mM) was substituted for SNP following the ET-1 control challenge. Figure 4B shows that the cGMP analog did not alter the recovery from ET-1 desensitization thus suggesting that NO may have a direct effect on the interaction of ET-1 with its receptor in renin-expressing cells. Importantly, activating two different receptor populations with successive doses of ET-1 and bradykinin (50 nM) (Fig. 5) 725 Ϯ 21 nM for ET-1 and bradykinin, respectively (n ϭ 18). These data suggest that the lack of a calcium response by successive doses of ET-1 are not due to depleted [Ca 2ϩ ] i stores and supports the notion of ET receptor desensitization. (Fig. 6 ). These data provide support for an ET-1-induced, IP-mediated release of [Ca 2ϩ ] i stores in As4.1 cells. Subsequent experiments used a concentration of 10 nM ET-1 because it resulted in a near-maximal IP response.
RESULTS

As4.1 cell calcium regulation by ET
Renin gene expression-transcription regulation by ET-1. Northern blot analysis was used to assess renin mRNA levels in control and ET-1-stimulated As4.1 cells. Cells were incubated for 24 h with 10 nM ET-1 or a super-maximal dose of 100 nM before harvesting the RNA. GAPDH mRNA was also quantified and used to correct for differences in gel loading. After stimulation of As4.1 cells with ET-1, renin expression was reduced to 32 Ϯ 3 and 32 Ϯ 6% of control at 10 and 100 nM, respectively (Fig. 7) . These results demonstrate that ET-1 is able to modulate renin gene expression in the As4.1 cell as well as demonstrating that a maximal inhibitory response occurs at a concentration of 10 nM (maximal IP response occurred near this dose as well). After inhibiting transcription with actinomycin D (10 g/ml), we used Northern blot analysis to investigate whether the kinetics of renin message decay, as a potential contributor to the observed decrease in expression, was altered by the presence of ET-1. The half-life of the renin message was unaffected by ET-1 (8.2 Ϯ 0.8 h for control vs. 8.4 Ϯ 0.7 h for 10 nM ET-1) (Fig. 8) , thus demonstrating that message decay was not responsible for the decreased expression and supporting the direct influence of ET-1 on renin gene transcription.
Recently, a 4,000-bp (Ϫ117 to Ϫ4100 relative to the transcription start site) sequence upstream of the renin proximal promoter (ϩ6 to Ϫ117) was determined to contain an enhancer sequence as well as other important sequences required for renin gene regulation (16) . Moreover, this construct may contain elements important for the effects of other physiological stimuli on renin gene transcription, including interleukin-1␤ (17) and mechanical force (21) . Therefore, we used the lu- ciferase derivative of a DNA construct containing this 4,000-bp sequence fused to the renin proximal promoter and a luciferase reporter gene (construct c) to assess the role of ET-1 in the transcriptional regulation of the renin gene. Luciferase activity was measured as an estimate of transcriptional activity. Transfected As4.1 cells were incubated with 10 nM ET-1 for 48 h before luciferase measurements. The 48-h exposure to ET-1 was selected based on preliminary transfection experiments from our laboratory (K. W. Gross) utilizing the 4,000-bp renin gene sequence fused to a chloramphenicol acetyltransferase reporter gene (data not shown). Medium was changed after the first 24 h, and fresh ET-1 was added. ␤-Galactosidase DNA was cotransfected with the luciferase construct and used to correct for variations in transfection efficiency. The results shown in Fig. 9 illustrate a reduction of transcriptional activity by 51% (P Ͻ 0.005) from control. Construct a (promoterless-luciferase construct) and construct b (luciferase plus the renin promoter) were used as negative controls.
DISCUSSION
The experiments described in the present study demonstrate that ET-1 stimulation of As4. (6, 8) .
ET receptor subtype. The study by Schroeder et al. (24) also indicated that the response of preglomerular artery vascular smooth muscle to ET-1 was mediated by the ET A receptor. This is consistent with our findings that ET-3, a selective ET B agonist, did not cause an increase in [Ca 2ϩ ] i and the ET A receptor antagonist BQ-123 was able to inhibit the response of As4.1 cells to ET-1. In further support for the role of ET A in mediating the actions of ET-1 on renin, it has been reported that blockade of the ET A receptor in chronically instrumented dogs results in an increase in plasma renin activity. Although the current findings demonstrate a role for the ET A receptor in the regulation of renin, it should be noted that Kramer et al. (13) found ET to act through ET B receptors in primary JG cells. In addition, Endemann et al. (7) found that ET-3 could elicit an increase in [Ca 2ϩ ] i in As4.1 cells. The difference may be explained by the higher concentration of ET-3 used (100 nM) by Endemann et al. (7) compared with the 10 nM used in the current study.
Given that repeated applications of ET-1 were unable to elicit a rise in [Ca 2ϩ ] i for ϳ35 min after the initial stimulus, we speculated that homologous desensitization of the ET-1 receptor had occurred. This speculation was supported by our data showing that addition of SNP, a NO donor, was able to abrogate the desensitization to the secondary challenge of ET-1 by 10 min. The reversal was not mimicked by cGMP, suggesting that the presence of NO may be effecting the affinity that ET has for its receptor. Furthermore, this finding is consistent with the finding of Goligorsky et al. (9) that NO may play a role in the physiological termination of an ET-1 stimulus through displacing bound ET-1 from its receptor. Whereas these findings strongly support a role for receptor desensitization, they do not completely rule out the possibility that [Ca 2ϩ ] i stores are depleted after the initial ET-1 stimulation. Furthermore, there is evidence that NO increases reuptake of calcium in the sarcoplasmic reticulum of vascular smooth muscle, making it possible that the effect of SNP to reduce the time between ET-1 responses is an artifact of refilling [Ca 2ϩ ] i stores more rapidly (5 Renin gene transcription. The data from the current study show that renin gene expression was markedly attenuated by the presence of ET-1. Moreover, this change in expression was not the result of posttranscriptional modification because it occurred independently of renin message decay kinetics. This by itself, suggests that the initial activation of signaling pathways by ET-1 ultimately leads to a decrease in renin gene transcription; however, to directly test this, we performed transient transfections in As4.1 cells with a 4,000-bp 5Ј-flanking region of the renin gene fused to a luciferase reporter gene. We selected this region based on studies done by our laboratory (K. W. Gross) where extensive promoter analysis revealed this to be a region of importance for the transcriptional regulation of the renin gene (16, 26) . The current study demonstrates for the first time that ET-1 stimulation leads to a direct inhibition of renin gene transcription. Importantly, the level of transcriptional inhibition was commensurate with what was observed by Northern blot analysis.
As4.1 cell model. To date most of the data pertaining to cellular control of renin by ET has been obtained by using primary JG cultures. The current study is the first to perform a detailed investigation of the effects of ET-1 on As4.1 and the subsequent regulation of renin. The As4.1 cell has proven to be a particularly useful in vitro model for JG cells. It was derived by transgenetargeted oncogenesis of renin-expressing cells in the mouse kidney and therefore expresses and secretes high levels of the endogenous mouse renin gene over many months in culture. Morphologically, the As4.1 cell is similar to bona fide JG cells in vivo because it contains large renin-positive secretory granules. In addition to the transcriptional regulation of renin that has been elucidated by using the As4.1 cell line, physiological studies of renin regulation have been performed. For example, cAMP analogs cause an increase in renin secretion from As4.1 cells (28) and interleukin-1␤ (17) , and more recently, mechanical strain (21, 22) has been shown to regulate the renin gene in a manner consistent with what would be expected in vivo.
In conclusion, the current study outlines a cellular pathway for the regulation of renin by ET-1. Initiation of this signaling pathway likely leads to activation of other downstream targets in the nucleus that result in a decrease in renin gene expression over hours and days. These studies suggest that vascular endothelium in the preglomerular artery may play a crucial role in the regulation of renin in vivo because ET-1 and NO, both products of vascular endothelium, are involved in the regulation of renin through receptor interactions, second messengers, and transcriptional regulation. Interestingly, the cellular and molecular pathways activated by ET-1 are similar to those activated by mechanical strain in the As4.1 cell line thus demonstrating the complexity of renin gene regulation by various physiological stimuli. Further elucidating the downstream targets of the signaling pathways activated by ET-1 in As4.1 cells and how this leads to the regulation of the renin gene remains to be elucidated.
